Skip to main content
Omkar Pharmachem Ltd. logo

Omkar Pharmachem Ltd. — Investor Relations & Filings

Ticker · 532167 ISIN · INE501C01015 BSE.NS Manufacturing
Open in API
Filings indexed 4 across all filing types
Latest filing 2026-05-27 Audit Report / Informat…
Country IN India
Listing BSE.NS 532167

About Omkar Pharmachem Ltd.

https://omkarpharmachem.co.in/

Omkar Pharmachem Ltd. is an enterprise primarily engaged in the manufacturing, trading, and distribution of active pharmaceutical ingredients (APIs) and chemical intermediates. The company focuses on providing a diverse range of chemical compounds and specialty chemicals tailored for healthcare and industrial applications. Its core operations involve the sourcing and supply of chemical formulations and raw materials used in various medicinal processes. Omkar Pharmachem Ltd. emphasizes maintaining a robust supply chain to serve its client base, ensuring the availability of essential chemical components for development and production. The portfolio includes a variety of organic and inorganic chemicals, catering to the specific requirements of laboratories and manufacturing units. The company maintains a focus on quality control and technical standards in the distribution of its chemical products.

Recent filings

Filing Released Lang Actions
Dear Sir/Ma''am, Please find Annual Secretarial Compliance report for the year ended 31.03.2026 of Omkar Pharmachem Limited.
Audit Report / Information Classification · 95% confidence The document is titled “Annual Secretarial Compliance Report” issued pursuant to SEBI LODR Regulation 24A (2) for the year ended 31 March 2026. It is a standalone compliance/audit report prepared by a Practicing Company Secretary and filed with the stock exchange. It is not a full Annual Report, Earnings Release, or proxy solicitation, nor is it merely an announcement. This matches the definition of a standalone audit/compliance report. Therefore, it is classified as Audit Report / Information (AR). FY 2026
2026-05-27 English
Omkar Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Omkar Pharmachem Ltd. has ....
Regulatory Filings Classification · 85% confidence The document is an intimation under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, notifying the stock exchange of a scheduled Board meeting to consider and approve audited financial results. It is an announcement to the exchange rather than the report itself and does not involve board member changes, so the appropriate category is a general regulatory announcement (Regulatory Filings).
2026-05-21 English
Dear Sir/Ma''am, Please find Intimation under Reg 30 of SEBI (LODR) Regulations, 2015 for change in name of Managing Director of the company.
Board/Management Information Classification · 90% confidence The document is an intimation under SEBI LODR Regulation 30 informing BSE and the market of a change in the name of the Managing Director. It announces a change in senior management personnel (board-level change). This aligns with the category for announcements of changes in directors or senior management (Board/Management Information).
2026-05-19 English
Dear Sir, Please find Newspaper Publication regarding Special Window for Transfer & Demat of Physical Shares.
Regulatory Filings Classification · 85% confidence The document is a BSE filing by Omkar Pharmachem Ltd notifying the exchange of a newspaper advertisement regarding a special window for share transfer and dematerialization, submitted to comply with a SEBI circular. It contains no financial statements, results, or management discussion – it is an operational/regulatory announcement. It does not fit any specific report categories (e.g., financial report, board change, dividend, share issue). Thus it is best classified as a general regulatory announcement.
2026-05-14 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.